Tests treatment safety and results for Severe Mental Illness
Official title Effectiveness of Mentalization-based Therapy (MBT)
ClinicalTrials.gov ID: NCT06659211
What this study is testing
- What it's testing
- The effects of psychological treatment, mentalization-based therapy, will be studied among persons with mental disorders seeking help from mental health care services.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- MBT Group:
- Age 18-64 years.
- Severe psychological symptoms, decreased functioning ability for long-term
- Challenges with interpersonal relationships and emotional regulation
- Patients willing to receive MBT
You likely can't join if
- MBT Group:
- Active substance use disorder (i.e., intoxication F1x.0, active dependence F1x.24, Continuous use F1x.25), a physiological withdrawal state F1x.3 and...
- Acute psychosis (defined as the recent onset of severe psychotic symptoms that interfere with functioning and are not yet in a therapeutic state...
- Disorder requiring inpatient treatment
- Previously received MBT
- Currently receiving psychotherapeutic treatment (previous psychotherapeutic treatment is not an exclusion) The exclusion criteria, therefore, do not...
See the full eligibility criteria
- MBT Group:
- Age 18-64 years.
- Severe psychological symptoms, decreased functioning ability for long-term
- Challenges with interpersonal relationships and emotional regulation
- Patients willing to receive MBT
- At least two of the following:
- Depression (diagnosis codes: F31.3-F31.5, F32.0-F32.9, F33.3-F33.9, F34.1) or anxiety disorder (diagnosis codes: F40-F48)
- Trauma background either as diagnosis or as need for treatment
- Signs of personality disorder (suspected or diagnosed) TAU group:
- Age 18-64 years.
- Severe psychological symptoms, decreased functioning ability for long-term
- Challenges with interpersonal relationships and emotional regulation
- At least two of the following
- Depression (diagnosis codes: F31.3-F31.5, F32.0-F32.9, F33.3-F33.9, F34.1) or anxiety disorder (diagnosis codes: F40-F48)
- Trauma background either as diagnosis or as need for treatment
- Signs of personality disorder (suspected or diagnosed)
- MBT Group:
- Active substance use disorder (i.e., intoxication F1x.0, active dependence F1x.24, Continuous use F1x.25), a physiological withdrawal state F1x.3 and F1x.4, or psychotic disorder F1x.5).
- Acute psychosis (defined as the recent onset of severe psychotic symptoms that interfere with functioning and are not yet in a therapeutic state. Non-acute psychotic symptoms are not exclusionary)
- Disorder requiring inpatient treatment
- Previously received MBT
- Currently receiving psychotherapeutic treatment (previous psychotherapeutic treatment is not an exclusion) The exclusion criteria, therefore, do not exclude psychotic disorders or any other psychiatric illness (except...
- Active substance use disorder (i.e., intoxication F1x.0, active dependence F1x.24, Continuous use F1x.25), a physiological withdrawal state F1x.3 and F1x.4, or psychotic disorder F1x.5).
- Acute psychosis (defined as the recent onset of severe psychotic symptoms that interfere with functioning and are not yet in a therapeutic state. Non-acute psychotic symptoms are not exclusionary)
- Disorder requiring inpatient treatment
- Previously received MBT
- Intensive psychotherapy (e.g. rehabilitative psychotherapy or similar weekly long-term psychotherapy)
The study team makes the final eligibility decision.
Where it's taking place
- Oulu, Finland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oulu, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.